CORC

浏览/检索结果: 共26条,第1-10条 帮助

已选(0)清除 条数/页:   排序方式:
Predicting and overcoming resistance to CDK9 inhibitors for cancer therapy 期刊论文
ACTA PHARMACEUTICA SINICA B, 2023, 卷号: 13
作者:  Hua, Chen;  Shena, Lijuan;  Zoua, Fengming;  Wua, Yun;  Wanga, Beilei
收藏  |  浏览/下载:14/0  |  提交时间:2023/11/10
Discovery of Pyrrolo[2,3-d]pyrimidine derivatives as potent and selective colony stimulating factor 1 receptor kinase inhibitors 期刊论文
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2022, 卷号: 243
作者:  Liang, Xiaofei;  Wang, Chun;  Wang, Beilei;  Liu, Juan;  Qi, Shuang
收藏  |  浏览/下载:31/0  |  提交时间:2022/12/23
Repurposing of the FGFR inhibitor AZD4547 as a potent inhibitor of necroptosis by selectively targeting RIPK1 期刊论文
ACTA PHARMACOLOGICA SINICA, 2022
作者:  Wang, Zuo-wei;  Zou, Feng-ming;  Wang, Ao-li;  Yang, Jing;  Jin, Rui
收藏  |  浏览/下载:21/0  |  提交时间:2022/12/22
CHMFL-26 is a highly potent irreversible HER2 inhibitor for use in the treatment of HER2-positive and HER2-mutant cancers 期刊论文
ACTA PHARMACOLOGICA SINICA, 2022
作者:  Cao, Jiang-yan;  Qi, Shuang;  Wu, Hong;  Wang, Ao-li;  Liu, Qing-wang
收藏  |  浏览/下载:95/0  |  提交时间:2022/03/28
Selectively targeting FLT3-ITD mutants over FLT3-wt by a novel inhibitor for acute myeloid leukemia 期刊论文
HAEMATOLOGICA, 2021, 卷号: 106
作者:  Wang, Aoli;  Hu, Chen;  Chen, Cheng;  Liang, Xiaofei;  Wang, Beilei
收藏  |  浏览/下载:43/0  |  提交时间:2021/04/26
Pharmacologically inhibiting phosphoglycerate kinase 1 for glioma with NG52 期刊论文
ACTA PHARMACOLOGICA SINICA, 2020
作者:  Wang, Wen-liang;  Jiang, Zong-ru;  Hu, Chen;  Chen, Cheng;  Hu, Zhen-quan
收藏  |  浏览/下载:28/0  |  提交时间:2020/11/26
Discovery of 6 '-chloro-N-methyl-5 '-(phenylsulfonamido)-[3,3 '-bipyridine]-5-carboxamide (CHMFL-PI4K-127) as a novel Plasmodium falciparum PI(4)K inhibitor with potent antimalarial activity against both blood and liver stages of Plasmodium 期刊论文
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2020, 卷号: 188
作者:  Liang, Xiaofei;  Jiang, Zongru;  Huang, Zhenghui;  Li, Feng;  Chen, Cheng
收藏  |  浏览/下载:28/0  |  提交时间:2020/11/26
Discovery and characterization of a novel highly potent and selective type II native and drug-resistant V299L mutant BCR-ABL inhibitor (CHMFL-ABL-039) for Chronic Myeloid Leukemia (CML) 期刊论文
CANCER BIOLOGY & THERAPY, 2019, 卷号: 20, 期号: 6, 页码: 877-885
作者:  Wu, Jiaxin;  Wang, Aoli;  Li, Xixiang;  Chen, Cheng;  Qi, Ziping
收藏  |  浏览/下载:30/0  |  提交时间:2019/11/27
Metabolic disturbances in non-obese women with polycystic ovary syndrome: a systematic review and meta-analysis 期刊论文
FERTILITY AND STERILITY, 2019, 卷号: 111, 期号: 1, 页码: 168-177
作者:  Zhu, Shiqin;  Zhang, Bingqian;  Jiang, Xiao;  Li, Zeyan;  Zhao, Shigang
收藏  |  浏览/下载:7/0  |  提交时间:2019/12/11
Over Ten-Cell Good Embryo Transfers on Day Three have Equivalent Clinical Outcomes with Those of Eight-Cell Embryos in Female Patients Aged <= 35 Years: A Retrospective Cohort Study 期刊论文
GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 2019, 卷号: 84, 期号: 3, 页码: 298-304
作者:  Zhao, Haibin;  Liu, Hui;  Li, Mei;  Ma, Shuiying;  Li, Cheng
收藏  |  浏览/下载:17/0  |  提交时间:2019/12/11


©版权所有 ©2017 CSpace - Powered by CSpace